June 20, 2024

FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.Read MoreLung Cancer, Drugs (Pharmaceuticals), Amgen Inc, Food and Drug Administration, Clinical TrialsNYT > Health

Leave a Reply

Your email address will not be published. Required fields are marked *